Tezepelumab in Patients With Severe Asthma: Response at 3 Months. Miralles-Lopez JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Cabrejos-Perotti S, et al. J Investig Allergol Clin Immunol 2024 Nov 25:0. doi: 10.18176/jiaci.1041.

Read + Share

Amedeo Smart

Independent Medical Education

Miralles-Lopez JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Cabrejos-Perotti S, et al. Tezepelumab in Patients With Severe Asthma: Response at 3 Months. J Investig Allergol Clin Immunol 2024 Nov 25:0. doi: 10.18176/jiaci.1041.
PMID: 39584417